CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
THUNDERBEAT +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02628093
NCT02628093N/ACompleted
CompareCT.gov

A Randomized Controlled Trial Comparing THUNDERBEAT to the Ligasure Energy Device During Laparoscopic Colon Surgery

Weill Medical College of Cornell University·interventional·Posted Dec 11, 2015·Updated Mar 18, 2020

In Brief

A clinical study evaluating THUNDERBEAT and LIGASURE for Colon Cancer. Completed, enrolled 73 participants across 1 site.

Detailed Summary

Prospective randomized controlled study, at Colon and Rectal Surgery, WMC/NYPH. Subjects undergoing Laparoscopic Left Colectomy will be randomized into 1 of 2 groups based on the instrument used for tissue dissection and vessel ligation: Group 1 - THUNDERBEAT Group 2 \- Ligasure Population

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColon Cancer
CountriesUnited States
CollaboratorsOlympus

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 11, 2015
Enrollment StartFeb 17, 2016
Primary CompletionMay 2, 2019
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 10.6 years ago

Interventions

THUNDERBEATdevice

Tissue dissection and vessels ligation

LIGASUREdevice

Tissue dissection and vessels ligation